Skip to main content

News & Events

News & Announcements

Paragon Bioservices Fills Key Leadership Position with New CFO Hire

BALTIMORE, June 6, 2018 /PRNewswire/ -- Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today that it filled a key leadership position with the appointment of seasoned executive Gerard Fleury as Chief Financial Officer (CFO).

"Our rapid growth, driven by the expanding needs of our client-base over the last few years, has warranted our need to invest in the ranks and capabilities of Paragon's leadership team," said President and CEO of Paragon Bioservices Pete Buzy. "Our focus has been on assembling experts at every level of the organization to expand our capabilities to Phase 3/Commercial to address our clients' continually advancing needs. As our new CFO, Gerard is an important addition to our leadership team who joins Paragon on the heels of several promotions and new executive hires we announced earlier this year."   

Mr. Fleury is an accomplished C-level leader with more than 25 years of experience across multiple industries. Most recently, he was the CFO of Pharmaceutics International, Inc. (Pii), a privately held CDMO providing dosage form development and manufacturing services to the global pharmaceutical industry, where he was responsible for the strategic and financial health of the company.

      Click here to read the rest of the story via PR Newswire